These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2686818)

  • 21. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management.
    Chambers MS; Garden AS; Kies MS; Martin JW
    Head Neck; 2004 Sep; 26(9):796-807. PubMed ID: 15350026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral care for the radiotherapy-treated head and neck cancer patient.
    Sullivan MD; Fleming TJ
    Dent Hyg (Chic); 1986 Mar; 60(3):112-4. PubMed ID: 2938989
    [No Abstract]   [Full Text] [Related]  

  • 23. Reducing xerostomia by IMRT: what may, and may not, be achieved.
    Eisbruch A
    J Clin Oncol; 2007 Nov; 25(31):4863-4. PubMed ID: 17971579
    [No Abstract]   [Full Text] [Related]  

  • 24. A critical component of supportive care.
    Murphy BA
    J Support Oncol; 2007 May; 5(5):228-9. PubMed ID: 17564152
    [No Abstract]   [Full Text] [Related]  

  • 25. Radiotherapy-induced salivary dysfunction.
    Ship JA; Hu K
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):29-36. PubMed ID: 15726520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dental implications and management of head and neck radiotherapy patients.
    Andrews N
    Ann R Australas Coll Dent Surg; 2000 Oct; 15():90-7. PubMed ID: 11709989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study.
    Buentzel J; Micke O; Adamietz IA; Monnier A; Glatzel M; de Vries A
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):684-91. PubMed ID: 16243440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beware the swing and a miss: baseball precautions for conformal radiotherapy.
    Harari PM
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):657-9. PubMed ID: 18262084
    [No Abstract]   [Full Text] [Related]  

  • 29. Managing complications of radiation therapy in head and neck cancer patients: Part II. Management of radiation-induced caries.
    Chai WL; Ngeow WC; Ramli R; Rahman RA
    Singapore Dent J; 2006 Dec; 28(1):4-6. PubMed ID: 17378334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoradiotherapy for head and neck cancer: 'local' side effects are actually systemic.
    J Support Oncol; 2006 Feb; 4(2):88. PubMed ID: 16499131
    [No Abstract]   [Full Text] [Related]  

  • 31. Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection?
    Vacha P; Fehlauer F; Mahlmann B; Marx M; Hinke A; Sommer K; Richter E; Feyerabend T
    Strahlenther Onkol; 2003 Jun; 179(6):385-9. PubMed ID: 12789464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The head and neck radiation oncology patient.
    Huber MA; Terezhalmy GT
    Quintessence Int; 2003 Oct; 34(9):693-717. PubMed ID: 14982224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of submandibular salivary gland transfer in preventing xerostomia in the chemoradiotherapy patient.
    Al-Qahtani K; Hier MP; Sultanum K; Black MJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jun; 101(6):753-6. PubMed ID: 16731395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevention and treatment of radiotherapy - induced xerostomia.
    Eisbruch A; Rhodus N; Rosenthal D; Murphy B; Rasch C; Sonis S; Scarantino C; Brizel D
    Semin Radiat Oncol; 2003 Jul; 13(3):302-8. PubMed ID: 12903018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
    Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors.
    Wijers OB; Levendag PC; Braaksma MM; Boonzaaijer M; Visch LL; Schmitz PI
    Head Neck; 2002 Aug; 24(8):737-47. PubMed ID: 12203798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
    Rhodus NL; Bereuter J
    J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients.
    Rades D; Fehlauer F; Bajrovic A; Mahlmann B; Richter E; Alberti W
    Radiother Oncol; 2004 Mar; 70(3):261-4. PubMed ID: 15064010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer.
    Saarilahti K; Kouri M; Collan J; Kangasmäki A; Atula T; Joensuu H; Tenhunen M
    Radiother Oncol; 2006 Mar; 78(3):270-5. PubMed ID: 16564589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of dentistry in palliative care of the head and neck cancer patient.
    Paunovich ED; Aubertin MA; Saunders MJ; Prange M
    Tex Dent J; 2000 Jun; 117(6):36-45. PubMed ID: 11857854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.